Xiaowei Yan
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 2%
- Long-Term Effects of COVID-19
Papers in
- Surgery 19
- Cholesterol and Lipid Metabolism 10
- Lipoproteins and Cardiovascular Health 7
-
- Blood Pressure and Hypertension Studies 5
- Co-authors
- Shuyang Zhang (12 shared papers)Taisheng Li (7 shared papers)Zhengyin Liu (6 shared papers)Jinglan Wang (6 shared papers)Yan Qin (4 shared papers)Fengchun Zhang (1 shared paper)Wen Zhang (1 shared paper)Qian Wang (1 shared paper)
- Journals
- Journal of Cardiovascular Pharmacology (3 papers)Atherosclerosis (3 papers)Medicine (2 papers)Food Chemistry (2 papers)Current Medical Research and Opinion (2 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Xiaowei Yan
74 papers receiving 2.0k citations
Xiaowei Yan's Hit Papers
Peers
Comparison fields: 5 of 127
- Infectious Diseases 825
- Neurology 385
- Internal Medicine 29
- Dermatology 75
- Cardiology and Cardiovascular Medicine 180
Countries citing papers authored by Xiaowei Yan
This map shows the geographic impact of Xiaowei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Yan more than expected).
Fields of papers citing papers by Xiaowei Yan
This network shows the impact of papers produced by Xiaowei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Yan. The network helps show where Xiaowei Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaowei Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China Hit paper breakdown → | 2020 | 970 |
| 2 | 2020 | 116 | |
| 3 | 2014 | 74 | |
| 4 | 2020 | 73 | |
| 5 | 2013 | 70 | |
| 6 | 2011 | 55 | |
| 7 | 2010 | 48 | |
| 8 | 2024 | 47 | |
| 9 | 2024 | 30 | |
| 10 | 2009 | 30 | |
| 11 | 2020 | 29 | |
| 12 | 2015 | 27 | |
| 13 | 2013 | 24 | |
| 14 | 2014 | 21 | |
| 15 | 2010 | 20 | |
| 16 | 2000 | 19 | |
| 17 | 2020 | 18 | |
| 18 | 2021 | 18 | |
| 19 | 2020 | 18 | |
| 20 | 2015 | 17 |
About Xiaowei Yan
Xiaowei Yan is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Molecular Biology, Oncology and Nutrition and Dietetics, having authored 75 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (10 papers), Lipoproteins and Cardiovascular Health (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Blood Pressure and Hypertension Studies (5 papers), COVID-19 Clinical Research Studies (5 papers), Long-Term Effects of COVID-19 (4 papers), Tryptophan and brain disorders (3 papers) and Sodium Intake and Health (2 papers). The work is most often cited by research in Infectious Diseases (825 citations), Neurology (385 citations), Internal Medicine (29 citations), Dermatology (75 citations) and Cardiology and Cardiovascular Medicine (180 citations). Xiaowei Yan has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Shuyang Zhang, Taisheng Li, Zhengyin Liu, Jinglan Wang, Yan Qin, Fengchun Zhang, Wen Zhang, Qian Wang, Yan Zhao and Xuan Zhang. Their work appears in journals such as Journal of Cardiovascular Pharmacology, Atherosclerosis, Medicine, Food Chemistry and Current Medical Research and Opinion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.